IPP Bureau
Hikal launches HPAPI laboratory at Integrated Innovation Centre, Pune
By IPP Bureau - October 14, 2025
The new cGMP-compliant HPAPI Laboratory is equipped with state-of-the-art isolators designed to meet Occupational Exposure Band 5 (OEB-5) requirements
Fredun Pharmaceuticals launches India's first pure Jain dog biscuit
By IPP Bureau - October 14, 2025
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
Mankind Pharma MD Rajeev Juneja appointed new president of PHDCCI
By IPP Bureau - October 14, 2025
Anil Gupta has been appointed as the Senior Vice President, and Sanjay Singhania has taken charge as the Vice President of PHDCCI
BioMed X launches women’s health R&D accelerator ‘XFem labs’ in Germany
By IPP Bureau - October 14, 2025
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
FDA approves AbbVie’s Upadacitinib for treatment of inflammatory bowel disease
By IPP Bureau - October 14, 2025
Updated indication expands treatment options for patients with ulcerative colitis and Crohn’s disease when tumor necrosis factor (TNF) blockers are clinically inadvisable
Gilead and Kite to transform cancer care with new data at ESMO 2025
By IPP Bureau - October 14, 2025
The study met its primary endpoint, demonstrating a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to chemotherapy
AbbVie showcases breakthrough ADC hard-to-treat cancers data at ESMO 2025
By IPP Bureau - October 14, 2025
New results from telisotuzumab adizutecan (Temab-A) and ABBV-706 demonstrate continued progress in AbbVie's antibody-drug conjugate (ADC) portfolio targeting difficult-to-treat cancers
Roche’s Elecsys pTau181 becomes first FDA-cleared blood test to rule out Alzheimer’s pathology in primary care
By IPP Bureau - October 14, 2025
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
Vasa Therapeutics secures FDA IND clearance to advance VS-041 into clinical trial for HFpEF
By IPP Bureau - October 14, 2025
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
EY to acquire life science tech firm Aqurance
By IPP Bureau - October 14, 2025
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Maverick Simulation installs 3D anatomage table at Safdarjung Hospital
By IPP Bureau - October 14, 2025
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
Biocon gets 1 USFDA observation for Cranbury site
By IPP Bureau - October 14, 2025
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
Well Pharmacy onboards Datamatics to automate medication record management
By IPP Bureau - October 14, 2025
Datamatics will automate the Medication Administration Record process by integrating its intelligent automation products, TruBot and TruCap+
IPP organizes panel discussion on "challenges and opportunities in Indian pharma sector" in Hyderabad on Oct. 15
By IPP Bureau - October 13, 2025
Speakers are: Ch. A. P. Rameswara Rao, National President, BDMAI; Dr. Paidi Yella Reddy, Founder, President & CEO, Sapala Organics; K. V. Rama Gopal, Site Manager & Executive Director, Clariant India; Dr. K. Nagaiah, Chief Scientist, CSIR - Indian Institute of Chemical Technology, Hyderabad; Dr. Satyanarayana Thirunahari, Senior General Manager - Process Safety & Engineering, Laurus Labs; and Yadavendra Shalgaonkar, Assistant General Manager - Tube Sales, Alleima India
